Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dentin hydroxyapatite is the primary inorganic mineral component of the tooth's dentin, organized into a complex crystalline structure of calcium and phosphate (PubChem CID 14781). When the protective layers of enamel or cementum are lost due to erosion or gingival recession, dentinal tubules—microscopic channels leading to the dental pulp—become exposed to the oral environment (StatPearls, NBK544332). According to the hydrodynamic theory, the movement of fluid within these exposed tubules in response to thermal, osmotic, or tactile stimuli triggers pulpal mechanoreceptors, resulting in the sharp pain characteristic of dentin hypersensitivity (Journal of Conservative Dentistry, PMC3010026). Therapeutic strategies focus on either desensitizing the pulpal nerves or physically sealing the tubule orifices to prevent fluid movement. Agents such as potassium nitrate work by increasing extracellular potassium concentration to inhibit nerve repolarization, while stannous fluoride and bioactive glasses promote the deposition of mineral precipitates onto the hydroxyapatite surface (NCBI, PMC3927677). Effective management of this target is essential for alleviating chronic dental pain and preventing further structural degradation of the tooth.
Nerve desensitization via potassium ion depolarization (StatPearls, NBK544332); physical occlusion of dentinal tubules to inhibit hydrodynamic fluid movement (Journal of Conservative Dentistry, PMC3010026); remineralization of the hydroxyapatite matrix (PubChem CID 14781).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin hydroxyapatite and exposed dentinal tubules (HAp).